Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 118 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $272,924 | +124.5% | 40,195 | +65.7% | 0.00% | – |
Q1 2023 | $121,568 | -62.6% | 24,265 | -63.6% | 0.00% | – |
Q4 2022 | $325,257 | +82.7% | 66,651 | +438.6% | 0.00% | – |
Q3 2022 | $178,000 | -75.4% | 12,375 | -72.3% | 0.00% | – |
Q4 2021 | $724,000 | +38.4% | 44,673 | +144.0% | 0.00% | – |
Q3 2021 | $523,000 | +139.9% | 18,311 | +154.2% | 0.00% | – |
Q1 2021 | $218,000 | -78.6% | 7,204 | -65.0% | 0.00% | -100.0% |
Q4 2020 | $1,020,000 | +200.0% | 20,607 | +132.5% | 0.00% | – |
Q3 2020 | $340,000 | +10.0% | 8,864 | +23.9% | 0.00% | – |
Q2 2020 | $309,000 | – | 7,157 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
Artal Group S.A. | 400,000 | $1,952 | 0.11% |
Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
XTX Topco Ltd | 38,574 | $188,241 | 0.04% |